Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Radiant Research, Inc.
mi
from
Denver, CO
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Clinical Research of South Florida
mi
from
Coral Gables, FL
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Pharmax Research Clinic
mi
from
Miami, FL
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Pharmax Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
University Clinical Research, Inc
mi
from
pembroke Pines, FL
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
University Clinical Research, Inc
mi
from
pembroke Pines, FL
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Miami Research Associates
mi
from
South Miami, FL
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Clinical Research Atlanta
mi
from
Stockbridge, GA
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Clinical Research Atlanta
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Radiant Research - Chicago
mi
from
Chicago, IL
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Radiant Research - Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Benchmark Research
mi
from
Metairie, LA
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Benchmark Research
mi
from
Metairie, LA
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Radiant Research
mi
from
St. Louis, MO
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Radiant Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Sundance Clinical Research, LLC
mi
from
St. Louis, MO
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Sundance Clinical Research, LLC
mi
from
St. Louis, MO
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Meridian Clinical Research
mi
from
Omaha, NE
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Meridian Clinical Research
mi
from
Omaha, NE
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Regional Clinical Research, Inc.
mi
from
Endwell, NY
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Regional Clinical Research, Inc.
mi
from
Endwell, NY
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Triangle Medical Research Associates
mi
from
Raleigh, NC
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Triangle Medical Research Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Radiant Research - Cincinnati
mi
from
Cincinnati, OH
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Radiant Research - Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Omega Medical Research
mi
from
Warwick, RI
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Spartanburg Medical Research
mi
from
Spartanburg, SC
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Spartanburg Medical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Health Concepts
mi
from
Rapid City, SD
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Clinical Research Associates, Inc. - Nashville
mi
from
Nashville, TN
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Clinical Research Associates, Inc. - Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Benchmark Research, Austin
mi
from
Austin, TX
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Benchmark Research, Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Benchmark Research Ft. Worth
mi
from
Ft. Worth, TX
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Benchmark Research Ft. Worth
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Benchmark Research San Angeolo
mi
from
San Angelo, TX
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Benchmark Research San Angeolo
mi
from
San Angelo, TX
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Jean Brown Research / Westside Medical
mi
from
Salt Lake City, UT
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Jean Brown Research / Westside Medical
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Advanced Clinical Research, Inc.
mi
from
West Jordan, UT
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Advanced Clinical Research, Inc.
mi
from
West Jordan, UT
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
PI-Coor Clinical Research, LLC
mi
from
Burke, VA
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
PI-Coor Clinical Research, LLC
mi
from
Burke, VA
Click here to add this to my saved trials
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated:  10/7/2015
Clinical Research Associates of Tidewater
mi
from
Norfolk, VA
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection
Status: Enrolling
Updated: 10/7/2015
Clinical Research Associates of Tidewater
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Birmingham, AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Huntsville, AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Mobile, AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Scottsboro, AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Scottsboro, AL
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Toney, AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Toney, AL
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Tuscumbia, AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Tuscumbia, AL
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Chandler, AZ
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Green Valley, AZ
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Green Valley, AZ
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Mesa, AZ
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Tucson, AZ
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Jonesboro, AR
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
North Little Rock, AR
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Searcy, AR
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Searcy, AR
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Anaheim, CA
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Chino, CA
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Cypress, CA
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials